v3.26.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 87 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Cash flows from operating activities:              
Net loss $ (34,099) $ (32,588) $ (26,820) $ (25,473) $ (66,687) $ (52,293)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         67 86  
Stock-based compensation         11,248 3,941  
Non-cash lease expense         360 108  
Changes in operating assets and liabilities:              
Other current assets and prepaid expenses         4,491 (429)  
Accounts payable         2,860 (896)  
Accrued expenses         (318) 3,447  
Other liabilities         37 (231)  
Operating lease liability         (357) (118)  
Net cash used in operating activities         (48,299) (46,385)  
Cash flows from investing activities:              
Purchases of property and equipment         (251) (83)  
Net cash used in investing activities         (251) (83)  
Cash flows from financing activities:              
Proceeds from issuance of private placement         187,263 0 $ 684,900
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised         86 123  
Proceeds from the exercise of employee stock options         32 0  
Net cash provided by financing activities         188,760 65,518  
Effect of exchange rate changes on cash and cash equivalents         (595) 592  
Net change in cash and cash equivalents         139,615 19,642  
Cash and cash equivalents, beginning of period   $ 15,483   $ 35,668 15,483 35,668  
Cash and cash equivalents, end of period $ 155,098   $ 55,310   155,098 55,310 $ 155,098
Supplemental disclosure of noncash investing and financing activities:              
Reclassification of SARs liability to equity         5,198 0  
Operating lease right-of use asset obtained in exchange for lease obligation         345 0  
Series B Warrants              
Cash flows from financing activities:              
Proceeds from Warrant Exercises         1,377 0  
Shares reserved for the January 2024 Pre-funded stock warrants              
Cash flows from financing activities:              
Proceeds from Warrant Exercises         2 0  
May 2025 PIPE Transaction              
Cash flows from financing activities:              
Proceeds from offering, net of issuance costs         0 60,661  
April 2025 PIPE Transaction              
Cash flows from financing activities:              
Proceeds from offering, net of issuance costs         $ 0 $ 4,734